| meta-analysis | Q815382 |
| scholarly article | Q13442814 |
| P50 | author | Nicolas Wentzensen | Q28360639 |
| Marc Arbyn | Q51773680 | ||
| P2093 | author name string | Lan Xu | |
| Christine Bergeron | |||
| Freija Verdoodt | |||
| P2860 | cites work | The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration | Q21092360 |
| Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesions | Q24198236 | ||
| American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer | Q24607403 | ||
| European Guidelines for Quality Assurance in Cervical Cancer Screening. Second edition--summary document | Q24644710 | ||
| Perinatal mortality and other severe adverse pregnancy outcomes associated with treatment of cervical intraepithelial neoplasia: meta-analysis | Q24647649 | ||
| What is "quality of evidence" and why is it important to clinicians? | Q24647929 | ||
| QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies | Q27861031 | ||
| Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews | Q29619492 | ||
| Metaprop: a Stata command to perform meta-analysis of binomial data | Q30916914 | ||
| The 2001 Bethesda System: terminology for reporting results of cervical cytology | Q34124761 | ||
| Atypical squamous cells, cannot exclude high-grade squamous intraepithelial lesion: diagnostic performance, human papillomavirus testing, and follow-up results | Q81149864 | ||
| Contribution of DNA ploidy image cytometry to the management of ASC cervical lesions | Q81622520 | ||
| Human papillomavirus-based triage of women showing a cervical cytology result of borderline or mild dyskaryosis | Q84041028 | ||
| Increased risk of preterm birth after treatment for CIN | Q84938570 | ||
| Worldwide burden of cervical cancer in 2008. | Q34176394 | ||
| Performance of p16/Ki-67 immunostaining to detect cervical cancer precursors in a colposcopy referral population | Q34543338 | ||
| Human papillomavirus testing and reporting rates in 2012: results of a College of American Pathologists national survey | Q35462749 | ||
| Risk assessment to guide the prevention of cervical cancer | Q36248638 | ||
| Five-year risks of CIN 3+ and cervical cancer among women who test Pap-negative but are HPV-positive | Q36740029 | ||
| Five-year risks of CIN 3+ and cervical cancer among women with HPV-positive and HPV-negative high-grade Pap results | Q36740033 | ||
| Five-year risks of CIN 3+ and cervical cancer among women with HPV testing of ASC-US Pap results | Q36740209 | ||
| 2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests | Q36955449 | ||
| Triage of women with equivocal or low-grade cervical cytology results: a meta-analysis of the HPV test positivity rate | Q37294687 | ||
| The role of HPV testing in patients with possible high-grade cervical cytology | Q37519886 | ||
| Atypical squamous cells, cannot exclude high-grade squamous intraepithelial lesion: review of ancillary testing modalities and implications for follow-up | Q37769051 | ||
| Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer | Q38064070 | ||
| 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors | Q38091972 | ||
| Accuracy of human papillomavirus testing on self-collected versus clinician-collected samples: a meta-analysis | Q38179114 | ||
| Expression of p16 in abnormal pap-tests as an indicator of CIN2+ lesions: a possible role in the low grade ASC/US and L/SIL (Ig) cytologic lesions for screening prevention of uterine cervical tumours | Q39845058 | ||
| Clinical significance of HPV DNA cotesting in Korean women with ASCUS or ASC-H. | Q42218921 | ||
| PAX1 methylation analysis by MS-HRM is useful in triage of high-grade squamous intraepithelial lesions | Q42235331 | ||
| Dual immunostaining of cervical cytology specimens with atypical squamous cells for p16/Ki-67 does not exclude the existence of a high-grade squamous intraepithelial lesion | Q42265661 | ||
| Cervical cytology with a diagnosis of atypical squamous cells, cannot exclude high-grade squamous intraepithelial lesion (ASC-H): a follow-up study with corresponding histology and significance of predicting dysplasia by human papillomavirus (HPV) D | Q42272332 | ||
| Use of HC2 to triage women with borderline and mild dyskaryosis in the UK. | Q42929938 | ||
| "Low-grade squamous intraepithelial lesion, cannot exclude high-grade squamous intraepithelial lesion" is a distinct cytologic category: histologic outcomes and HPV prevalence | Q43424946 | ||
| Reflex high risk HPV testing in atypical squamous cells, cannot exclude high grade intraepithelial lesion: a large institution's experience with the significance of this often ordered test | Q43464552 | ||
| Performance of ProEx C and PreTect HPV-Proofer E6/E7 mRNA tests in comparison with the hybrid capture 2 HPV DNA test for triaging ASCUS and LSIL cytology | Q43524242 | ||
| p16(INK4a) is superior to high-risk human papillomavirus testing in cervical cytology for the prediction of underlying high-grade dysplasia | Q43613013 | ||
| The use of p16(INK4A) immunocytochemistry in "Atypical squamous cells which cannot exclude HSIL" compared with "Atypical squamous cells of undetermined significance" in liquid-based cervical smears | Q43613747 | ||
| Comparison of two signal-amplification DNA tests for high-risk HPV as an aid to colposcopy. | Q43855331 | ||
| Outcome of "Atypical squamous cells" in a cervical cytology screening program: implications for follow up in resource limited settings | Q44294578 | ||
| Adjunctive human papillomavirus DNA testing is a useful option in some clinical settings for disease risk assessment and triage of females with ASC-H Papanicolaou test results | Q44527622 | ||
| Linear array genotyping and hybrid capture II assay in detecting human papillomavirus genotypes in women referred for colposcopy due to abnormal Papanicolaou smear | Q44779725 | ||
| Reflex high-risk human papilloma virus DNA test is useful in the triage of women with atypical squamous cells cannot exclude high-grade squamous intraepithelial lesion | Q44823612 | ||
| Follow-up outcomes in a large cohort of patients with human papillomavirus-negative ASC-H cervical screening test results | Q45080523 | ||
| The age-specific relationships of abnormal cytology and human papillomavirus DNA results to the risk of cervical precancer and cancer. | Q46032195 | ||
| Triage of atypical squamous cells of undetermined significance with hybrid capture II: colposcopy and histologic human papillomavirus correlation | Q46040726 | ||
| Improved abnormal Pap smear triage using cervical cancer biomarkers. | Q50914416 | ||
| Cervical cytology of atypical squamous cells-cannot exclude high-grade squamous intraepithelial lesion (ASC-H): characteristics and histologic outcomes. | Q53631920 | ||
| Diagnostic performance of p16 staining in atypical squamous cells 'cannot exclude high-grade squamous epithelial lesion' in predicting high-grade cervical pathology. | Q54339754 | ||
| American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology Screening Guidelines for the Prevention and Early Detection of Cervical Cancer | Q57089342 | ||
| HPV testing results and histologic follow-up in women with ASC-H cytology in different age groups | Q60151640 | ||
| Atypical squamous cells, cannot exclude high grade intraepithelial lesion (ASC-H): does HPV matter? | Q79437007 | ||
| High-risk human papillomavirus DNA testing and high-grade cervical intraepithelial lesions | Q79929588 | ||
| Should women with atypical squamous cells, cannot exclude high-grade squamous intraepithelial lesion, receive reflex human papillomavirus-DNA testing? | Q81069310 | ||
| Detection of human papillomavirus genotypes among high-risk women: a comparison of hybrid capture and linear array tests | Q81148024 | ||
| P433 | issue | 4 | |
| P304 | page(s) | 261-272 | |
| P577 | publication date | 2015-11-30 | |
| P1433 | published in | Cancer Cytopathology | Q13452937 |
| P1476 | title | Triage of ASC-H: A meta-analysis of the accuracy of high-risk HPV testing and other markers to detect cervical precancer | |
| P478 | volume | 124 |
| Q87735846 | HPV test results provide useful risk stratification information in women with ASC-H Pap test findings |
| Q95728083 | Histopathology of Women with “Atypical Squamous Cells Cannot Exclude High-Grade Squamous Intraepithelial Lesion” (ASC-H) Smears |
| Q40373166 | Indications for p16/Ki-67 in cervical cytology |
| Q40341777 | Quantitative Measurement of L1 Human Papillomavirus Type 16 Methylation for the Prediction of Preinvasive and Invasive Cervical Disease |
| Q40686074 | Reply to HPV test results provide useful risk stratification information in women with ASC-H Pap test findings |
Search more.